Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
PRNewswire - July 8, 2003
Jacques Boisvert, President and Chief Executive Officer of Dosex Inc., who has more than 20 years experience as Senior Executive of major pharmaceutical companies in Canada and abroad, said his past experience with the ALR Technologies medication reminder devices gives him confidence in creating renewed consumer demand and in expanding the market potential for the ALRT Med Reminder devices.
"As President and General Manager of Novopharm Quebec and Technilab Pharma Inc., we purchased several hundred thousand of dollars of the initial version of ALRT Med Reminder devices. They were available through retail drugstores, while the pharmacist programmed each device according to patient's needs.
Numerous testimonies from patients and pharmacists reported a marked improvement in patients complying with the prescribed medications," said Boisvert. "With the significant improvements and enhanced features of the new version of the PC 100, we can achieve significant market penetration in Canada."
"Canadian pharmacists are very attentive to the needs of patients and the importance of reliable and user-friendly Med Reminder devices to enhance overall compliance," Boisvert adds. "We are excited about our agreement with ALR Technologies that allows us to re-enter the market. All stakeholders, namely pharmaceutical companies, physicians, pharmacists, government authorities, insurance companies are all looking for ways of reducing healthcare costs and enhancing patient health outcomes."
In Canada, the direct cost of non-compliance is estimated at more than $10 billion due to undue side-effects and hospitalization. A breakthrough device like the ALRT Med Reminder PC100 can greatly contribute to reducing that cost, while helping the patient obtain full benefits from the prescribed treatment.
ALRT Med Reminder devices address the problem of patient "non-compliance" with medication -- more readily understood as "not taking your medicine on- time as prescribed" -- which according to the office of the U.S. Inspector General causes 10 percent of all hospitalizations and more than 125,000 deaths annually in the cardiovascular area alone.
Sidney Chan, Chairman and Chief Executive Officer of ALR Technologies, said that the time and investment spent on improving and expanding the company's product portfolio will help greatly in generating market acceptance with drug companies, pharmacies, medical centers and patients. "We made a significant investment to improve our products, as we utilized feedback from consumers to develop features that now allow us to provide the top-of-line and easy to use medication compliance devices that meet the various needs of users."
"We devoted more than two years in development in order to have the best products and, a portfolio that provides easy to use devices to fit various needs. Thus, we will be introducing other products later this year," said Chan.
Small enough to fit in the palm of your hand, ALR Technologies Med Reminders are easy to use and affordably priced. They remind to take their medications on time with both and audio and visual cue. ALR Technologies is currently selling a manually programmed reminder device as well as the PC100, which is programmed with a computer. It can be set quickly and easily at a pharmacy or medical clinic and sent home with the patient. Furthermore, either the patient or a caregiver can easily program the Med Reminder device.
People of all ages -- whether too busy or just plain forgetful, especially when taking multiple medications -- fail to take a variety of medications, including antibiotics, hypertension drugs, diabetes medications, asthma medications, cholesterol lowering drugs, birth control pills, time-critical HIV/AIDS drug regimens, depression treatments, glaucoma treatments, blood sugar level testing for diabetics and many more.
In addition to 10 percent of all hospitalizations, the office of U.S. Inspector General reports that up to 23 percent of nursing home admissions could be prevented if people took medications on time, as prescribed. It is estimated that medication non-compliance results in additional healthcare costs -- including those associated with nursing home admissions -- in excess of $100 billion per year in United States.
ALR Technologies Inc. (OTC Bulletin Board: ALRT), produces and markets ALRT Med Reminders(TM), which are available in the USA at Eckerd stores system-wide and at other select retailers. The devices are also available for purchase at http://www.takemedsontime.com or by calling toll-free at 877-257-6337.
For more information on ALRT Med Reminders(TM) and medication non-compliance, go to the company web-site http://www.alrt.com.
This release contains certain "forward-looking statements" relating to ALR Tech's business, and these statements reflect the current views of ALR Tech with respect to future events and are subject to certain risks, uncertainties and assumptions. There are many factors that could cause the actual results, performance or achievements of ALR Tech and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements.
SOURCE ALR Technologies Inc.
Web Site: http://www.alrt.com
030708
PR030708
Copyright © 2003 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .